Safety and Efficacy of Rivaroxaban and Apixaban in Comparison to Warfarin in Left Ventricular Clot- Clinical Trial
Condition:   Left Ventricular Thrombus Interventions:   Drug: Warfarin;   Drug: Rivaroxaban 20 MG Oral Tablet;   Drug: Apixaban 5mg or 2.5mg oral tablet Sponsors:   Peshawar Institute of Cardiology;   Getz Pharma Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - August 2, 2023 Category: Research Source Type: clinical trials